Cezar Iliescu

5.8k total citations · 2 hit papers
175 papers, 3.8k citations indexed

About

Cezar Iliescu is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Cezar Iliescu has authored 175 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Cardiology and Cardiovascular Medicine, 47 papers in Surgery and 43 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Cezar Iliescu's work include Chemotherapy-induced cardiotoxicity and mitigation (54 papers), Cardiac Imaging and Diagnostics (41 papers) and Coronary Interventions and Diagnostics (24 papers). Cezar Iliescu is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (54 papers), Cardiac Imaging and Diagnostics (41 papers) and Coronary Interventions and Diagnostics (24 papers). Cezar Iliescu collaborates with scholars based in United States, Türkiye and Greece. Cezar Iliescu's co-authors include Juan Lopez‐Mattei, Nicolas L. Palaskas, Konstantinos Marmagkiolis, Jean Bernard Durand, Mehmet Çilingiroğlu, Jean‐Bernard Durand, Anita Deswal, Joerg Herrmann, Eric H. Yang and Peter Kim and has published in prestigious journals such as Circulation, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Cezar Iliescu

162 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate

2006 858 citations Cezar Iliescu, Jean‐Bernard Durand et al. profile →
Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment

2020 350 citations Nicolas L. Palaskas, Juan Lopez‐Mattei et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cezar Iliescu United States	27	2.3k	1.1k	840	639	581	175	3.8k
Michael G. Fradley United States	28	2.0k 0.9×	1.4k 1.2×	501 0.6×	497 0.8×	313 0.5×	139	3.5k
Stéphane Éderhy France	27	1.4k 0.6×	1.3k 1.1×	283 0.3×	525 0.8×	332 0.6×	116	3.0k
Dania Mohty France	29	4.1k 1.7×	872 0.8×	1.0k 1.2×	942 1.5×	1.1k 1.9×	101	5.2k
Juan Carlos Plana United States	30	5.5k 2.3×	1.9k 1.6×	2.4k 2.8×	819 1.3×	404 0.7×	63	6.3k
Kerry L. Reynolds United States	36	901 0.4×	3.7k 3.2×	410 0.5×	1.2k 1.9×	332 0.6×	153	5.0k
Dipti Gupta United States	19	1.2k 0.5×	1.2k 1.0×	352 0.4×	393 0.6×	177 0.3×	35	2.3k
Avirup Guha United States	24	1.3k 0.5×	612 0.5×	297 0.4×	372 0.6×	327 0.6×	174	2.2k
Günter Christ Austria	23	1.0k 0.4×	397 0.3×	318 0.4×	301 0.5×	532 0.9×	95	2.3k
Julia Meißner Germany	26	1.0k 0.4×	676 0.6×	572 0.7×	328 0.5×	344 0.6×	72	2.5k
Umesh C. Sharma United States	22	1.3k 0.6×	566 0.5×	227 0.3×	263 0.4×	543 0.9×	91	3.1k

Countries citing papers authored by Cezar Iliescu

Since Specialization

Citations

This map shows the geographic impact of Cezar Iliescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cezar Iliescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cezar Iliescu more than expected).

Fields of papers citing papers by Cezar Iliescu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cezar Iliescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cezar Iliescu. The network helps show where Cezar Iliescu may publish in the future.

Co-authorship network of co-authors of Cezar Iliescu

This figure shows the co-authorship network connecting the top 25 collaborators of Cezar Iliescu. A scholar is included among the top collaborators of Cezar Iliescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cezar Iliescu. Cezar Iliescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ali, Abdelrahman, Lu Yang, Shaden Khalaf, et al.. (2024). Use of positron emission tomography for the diagnosis of immune-checkpoint inhibitor| myocarditis. Journal of Nuclear Cardiology. 39. 101909–101909.

Siddiqui, Bilal A., Nicolas L. Palaskas, Sreyashi Basu, et al.. (2024). Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis. Cancer Immunology Research. 12(8). 964–987. 7 indexed citations

Caldwell, Rebecca L., Syed Wamique Yusuf, Efstratios Koutroumpakis, et al.. (2024). Elevated IL-6 and Tumor Necrosis Factor-α in Immune Checkpoint Inhibitor Myocarditis. SHILAP Revista de lepidopterología. 12(5). 88–88. 6 indexed citations

Monlezun, Dominique, R. Patel, Dan Halperin, et al.. (2023). Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a focus on the “forgotten pulmonic valve”. Frontiers in Cardiovascular Medicine. 9. 1071138–1071138. 2 indexed citations

Koutroumpakis, Efstratios, Christopher Black, Juhee Song, et al.. (2023). Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis. Frontiers in Cardiovascular Medicine. 9. 1073804–1073804. 3 indexed citations

Tummala, Sudhakar, et al.. (2023). Management of respiratory failure in immune checkpoint inhibitors-induced overlap syndrome: a case series and review of the literature. BMC Anesthesiology. 23(1). 310–310. 5 indexed citations

Monlezun, Dominique, et al.. (2022). Artificial Intelligence-Augmented Propensity Score, Cost Effectiveness and Computational Ethical Analysis of Cardiac Arrest and Active Cancer with Novel Mortality Predictive Score. Medicina. 58(8). 1039–1039. 11 indexed citations

Monlezun, Dominique, et al.. (2021). confinamientos de la poblacion por el Covid-19 pueden empeorar las desigualdades socioeconomicas que impactan de forma desproporcionada en las minorias raciales: rentabilidad aumentada por aprendizaje automatico y analisis etico computacional. SHILAP Revista de lepidopterología. 32(3). 759–800. 2 indexed citations

Okutucu, Sercan, et al.. (2020). Evaluation of Effectiveness and Safety of Transcatheter Mitral Valve Repair Under Moderate Conscious Sedation. The Journal of invasive cardiology. 32(6). 206–210. 5 indexed citations

10.

Marmagkiolis, Konstantinos, et al.. (2020). Evaluation of Effectiveness and Safety of Left Atrial Appendage Closure Under Moderate Conscious Sedation. The Journal of invasive cardiology. 32(9). 358–362. 6 indexed citations

11.

Aponte, Maria, Peter Kim, Anita Deswal, et al.. (2020). Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Therapy: The Cytokine Release Syndrome and Associated Arrhythmias. SHILAP Revista de lepidopterología. 3(3). 113–120. 12 indexed citations

12.

Çilingiroğlu, Mehmet, et al.. (2020). CRT-600.55 Left Atrial Appendage Closure Can Safely Be Performed Under Conscious Sedation. JACC: Cardiovascular Interventions. 13(4). S61–S61.

13.

Aziz, Moez Karim, Dinu Valentin Balanescu, Teodora Donisan, et al.. (2020). INTRACORONARY IMAGING-GUIDED DISCONTINUATION OF DUAL ANTIPLATELET THERAPY IN STENTED PATIENTS REQUIRING EXPEDITED CANCER TREATMENT. Journal of the American College of Cardiology. 75(11). 1408–1408. 1 indexed citations

14.

Zarifa, Abdulrazzak, Juan Lopez‐Mattei, Nicolas L. Palaskas, et al.. (2020). Immune Checkpoint Inhibitors (ICIs)-Related Cardiotoxicity. Advances in experimental medicine and biology. 1244. 277–285. 11 indexed citations

15.

Yang, Eric H., Joerg Herrmann, Cezar Iliescu, et al.. (2019). Applications of Cardiac Computed Tomography in the Cardio-Oncology Population. Current Treatment Options in Oncology. 20(6). 47–47. 12 indexed citations

16.

Schechter, Michael S., Dinu Valentin Balanescu, Teodora Donisan, et al.. (2018). An update on the management and outcomes of cancer patients with severe aortic stenosis. Catheterization and Cardiovascular Interventions. 94(3). 438–445. 22 indexed citations

17.

Iliescu, Cezar, et al.. (2015). Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion. Journal of the American College of Cardiology. 66(10). 1119–1128. 76 indexed citations

18.

Marmagkiolis, Konstantinos, Abdul Hakeem, Mehmet Çilingiroğlu, et al.. (2015). Safety and Efficacy of Stent Retrievers for the Management of Acute Ischemic Stroke. JACC: Cardiovascular Interventions. 8(13). 1758–1765. 25 indexed citations

19.

Iliescu, Cezar, Guilherme Silva, José Banchs, et al.. (2013). OPTICAL COHERENCE TOMOGRAPHY-GUIDED ANTIPLATELET THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE AND CANCER: THE PROTECT-OCT REGISTRY. Journal of the American College of Cardiology. 61(10). E1128–E1128. 1 indexed citations

20.

Deschildre, A., Laurent Béghin, Julia Salleron, et al.. (2011). Home telemonitoring (forced expiratory volume in 1 s) in children with severe asthma does not reduce exacerbations. European Respiratory Journal. 39(2). 290–296. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact